Biotechnology Product Manufacturing

First Research, Inc.
June 9, 2014
10 Pages - SKU: FRRS5265190
Countries covered: United States

Biotechnology Product Manufacturing

Brief Excerpt from Industry Overview Chapter:

Companies in this industry manufacture drugs, therapies, vaccines, genetically modified food and fuel, and other products based on genetically manipulated compounds. Major companies include US-based Amgen, Biogen Idec, Genentech (owned by Switzerland-based Roche), and Monsanto, as well as Cangene (Canada), CSL (Australia), Merck KGaA (Germany), and the biotech research arms of major international pharmaceutical companies such as Sanofi (France, owns Genzyme).

The global biotechnology industry includes about 7,000 companies with total revenue of about $120 billion, according to Israeli business magazine Globes. Top regions for biotechnology include the US and Canada, Australia, and Europe, according to Ernst & Young.

The US biotechnology product manufacturing industry includes about 1,800 companies with combined annual revenue of around $90 billion. Because many drugs are now developed using biotechnology, the biotechnology and pharmaceutical industries overlap considerably. Pharmaceutical Manufacturing is covered in a separate industry report.

COMPETITIVE LANDSCAPE

Demand for biotechnology in the fields of medicine, agriculture, food, and science is driven by insurers' willingness to pay for new medical treatments, the global need to produce more food for a rapidly expanding population, and scientists' desire to find solutions for complex scientific and medical issues. Funding for biotech research is often provided by venture capital funds hoping to cash in on new products. The profitability of individual companies depends on the discovery and effective marketing of new products. Because the market for potential products is so large, small biotechnology companies can co-exist successfully with...



More Manufacturing, Packaging & Detailing reports by First Research, Inc.

Pharmaceutical Manufacturing by First Research, Inc.
Pharmaceutical ManufacturingBrief Excerpt from Industry Overview Chapter:Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, ...
See all reports like this >>

More United States Manufacturing, Packaging & Detailing reports

Pharmaceuticals and Healthcare Report - United States Q3 2014 by Business Monitor International
United States Pharmaceuticals and Healthcare Report Q3 2014BMI View: The US will remain the most attractive pharmaceutical market in the world for the foreseeablefuture. There ...
Pharmaceutical Manufacturing by First Research, Inc.
Pharmaceutical ManufacturingBrief Excerpt from Industry Overview Chapter:Companies in this industry manufacture and process pharmaceutical products. Major companies include Bristol-Myers Squibb, Eli Lilly, Johnson & Johnson, ...
Drugs & antibiotics materials used by the Animal Slaughtering & Processing Industry-Materials & Manufacturing Report - U.S. 2014 by Barnes Reports
2014 U.S. Drugs & antibiotics materials used by the Animal Slaughtering & Processing Industry-Materials & Manufacturing ReportThe 2014 U.S. Drugs & antibiotics materials used by ...
Freedonia Focus on Pharmaceuticals: United States by Freedonia Focus Reports
Freedonia Focus on Pharmaceuticals: United StatesThis report forecasts US pharmaceutical (prescription and over-the-counter) shipments and demand in US dollars at the manufacturers' level to 2018. ...
See all reports like this >>

More United States reports

The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United States by Icon Group International, Inc.
The 2013-2018 Outlook for Collagen and (hyaluronic Acid) HA-Based Biomaterials in the United StatesThis econometric study covers the latent demand outlook for collagen and (hyaluronic ...
The 2013-2018 Outlook for Relish in the United States by Icon Group International, Inc.
This econometric study covers the latent demand outlook for relish across the states and cities of the United States. Latent demand (in millions of U.S. ...
D&B Country RiskLine Report: The United States of America by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 129  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!